
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **ACTG2 (Actin Gamma 2)**: Involved in muscle contraction and cytoskeletal structure.<br>- **TAGLN (Transgelin)**: Associated with smooth muscle differentiation and actin-binding.<br>- **MYLK (Myosin Light Chain Kinase)**: Plays a role in muscle contraction.<br>- **TPM2 (Tropomyosin 2)**: Involved in muscle contraction regulation.<br>- **MYL9 (Myosin Light Chain 9)**: Associated with muscle contraction.<br>- **ACTA2 (Actin Alpha 2, Smooth Muscle)**: A marker for smooth muscle cells.<br>- **SYNM (Synemin)**: Intermediate filament protein, often found in muscle cells.<br>- **CTGF (Connective Tissue Growth Factor)**: Involved in cell adhesion and migration, often in stromal cells.<br>- **SERPINH1 (Serpin Family H Member 1)**: Involved in collagen synthesis and folding.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT81, KRT17, KRT16, KRT23**: Keratins are structural proteins in epithelial cells, often associated with skin and hair follicle cells.<br>- **DSG3 (Desmoglein 3), DSC2 (Desmocollin 2)**: Components of desmosomes, important for cell-cell adhesion in epithelial tissues.<br>- **GABRP (Gamma-Aminobutyric Acid Type A Receptor Pi Subunit)**: Expressed in epithelial cells, particularly in breast tissue.<br>- **CD24**: A marker often found in epithelial and cancer stem cells.<br>- **S100A1, S100P, S100A6**: Calcium-binding proteins, often expressed in epithelial cells and involved in cell cycle progression and differentiation.<br>- **LY6E (Lymphocyte Antigen 6 Complex, Locus E)**: Expressed in epithelial cells and involved in immune response modulation.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:<br>- **Smooth Muscle Markers**: ACTA2, TAGLN, MYLK, TPM2, MYL9, SYNM are strongly indicative of smooth muscle cells.<br>- **Epithelial Markers**: KRT81, KRT17, KRT16, DSG3, DSC2, CD24, S100 family proteins suggest an epithelial origin, possibly basal or luminal epithelial cells in breast tissue.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of smooth muscle and epithelial markers, the most probable general cell type is **myoepithelial cells**. These cells have characteristics of both epithelial and smooth muscle cells and are found in the breast tissue.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Myoepithelial Cells**: Given the strong presence of both smooth muscle and epithelial markers, myoepithelial cells are the most likely subtype.<br>2. **Basal Epithelial Cells**: The presence of keratins and desmosomal proteins suggests a basal epithelial phenotype.<br>3. **Luminal Progenitor Cells**: Some markers like CD24 and S100 proteins can also be expressed in luminal progenitor cells, although less likely given the strong smooth muscle signature.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of **myoepithelial cells**. This conclusion is supported by the co-expression of smooth muscle markers (e.g., ACTA2, TAGLN) and epithelial markers (e.g., KRT17, DSG3). Myoepithelial cells are known to play a role in the structural integrity and function of breast tissue, particularly in the context of cancer.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**:<br>   - The markers used in the annotation (e.g., ACTG2, TAGLN, MYLK, TPM2, MYL9, ACTA2, SYNM, CTGF, SERPINH1, KRT81, KRT17, KRT16, KRT23, DSG3, DSC2, GABRP, CD24, S100A1, S100P, S100A6, LY6E) are all present in the provided marker list.<br>   - The markers are consistent with the identified cell type of myoepithelial cells, which are known to express both smooth muscle markers (e.g., ACTA2, TAGLN) and epithelial markers (e.g., KRT17, DSG3).<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation acknowledges the presence of both smooth muscle and epithelial markers, which is characteristic of myoepithelial cells. This suggests a mixed phenotype inherent to myoepithelial cells rather than a mixture of distinct cell types.<br>   - The analysis also considers the possibility of basal epithelial cells and luminal progenitor cells, but the strong presence of smooth muscle markers supports the primary annotation of myoepithelial cells.<br><br>Overall, the annotation is well-supported by the marker list and the known characteristics of myoepithelial cells, making the validation successful.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">myoepithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>basal epithelial cells</li><li>luminal progenitor cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a well-reasoned approach to identifying the cell types present in the single-cell dataset derived from human breast cancer tissue. The analysis effectively considers a broad range of markers, balancing between smooth muscle and epithelial markers, which is crucial for identifying myoepithelial cells. This is a strength, as myoepithelial cells are indeed characterized by the expression of both smooth muscle markers (e.g., ACTA2, TAGLN, MYLK) and epithelial markers (e.g., KRT17, DSG3).<br><br>The annotation process is thorough, with a clear step-by-step methodology that includes listing key functional and cell type markers, cross-referencing with known databases, and determining the most probable cell types. This structured approach ensures that the analysis is comprehensive and scientifically grounded.<br><br>However, there are a few areas where the annotation could be improved. While the analysis does consider the rank of the markers, it could place more emphasis on the most highly ranked markers, as these are likely to be more indicative of the dominant cell type. For instance, PCP4 and HRCT1, which appear early in the marker list, are not discussed in the annotation. These markers could provide additional insights into the cell type or state and should be considered in the analysis.<br><br>Additionally, while the annotation identifies myoepithelial cells as the primary cell type, it also suggests basal epithelial cells and luminal progenitor cells as possible subtypes. This is a reasonable consideration given the marker profile, but the analysis could benefit from a more detailed discussion of how these subtypes are distinguished from each other based on the marker list.<br><br>Overall, the annotation is scientifically accurate and provides a comprehensive view of the cell types present, with a balanced consideration of multiple markers. There are no obvious misclassifications, and the analysis captures the general picture of the cell populations well. However, a more detailed consideration of the most highly ranked markers and a clearer distinction between subtypes would enhance the analysis.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    